355 related articles for article (PubMed ID: 34069652)
1. The Role of Fatty Acids in Ceramide Pathways and Their Influence on Hypothalamic Regulation of Energy Balance: A Systematic Review.
Reginato A; Veras ACC; Baqueiro MDN; Panzarin C; Siqueira BP; Milanski M; Lisboa PC; Torsoni AS
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069652
[TBL] [Abstract][Full Text] [Related]
2. Potential relationship between dietary long-chain saturated fatty acids and hypothalamic dysfunction in obesity.
Sergi D; Williams LM
Nutr Rev; 2020 Apr; 78(4):261-277. PubMed ID: 31532491
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
4. Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance.
Contreras C; González-García I; Martínez-Sánchez N; Seoane-Collazo P; Jacas J; Morgan DA; Serra D; Gallego R; Gonzalez F; Casals N; Nogueiras R; Rahmouni K; Diéguez C; López M
Cell Rep; 2014 Oct; 9(1):366-377. PubMed ID: 25284795
[TBL] [Abstract][Full Text] [Related]
5. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
6. Phlorotannins from
Oh S; Son M; Choi J; Choi CH; Park KY; Son KH; Byun K
Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31600939
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
8. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle.
Blachnio-Zabielska A; Baranowski M; Zabielski P; Gorski J
J Cell Physiol; 2010 Nov; 225(3):786-91. PubMed ID: 20568228
[TBL] [Abstract][Full Text] [Related]
9. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
Bellini L; Campana M; Mahfouz R; Carlier A; Véret J; Magnan C; Hajduch E; Le Stunff H
Expert Opin Ther Targets; 2015; 19(8):1037-50. PubMed ID: 25814122
[TBL] [Abstract][Full Text] [Related]
10. Gastric Bypass Surgery Improves the Skeletal Muscle Ceramide/S1P Ratio and Upregulates the AMPK/ SIRT1/ PGC-1α Pathway in Zucker Diabetic Fatty Rats.
Huang H; Aminian A; Hassan M; Dan O; Axelrod CL; Schauer PR; Brethauer SA; Kirwan JP
Obes Surg; 2019 Jul; 29(7):2158-2165. PubMed ID: 30809769
[TBL] [Abstract][Full Text] [Related]
11. Ceramide and Sphingosine 1-Phosphate in Liver Diseases.
Park WJ; Song JH; Kim GT; Park TS
Mol Cells; 2020 May; 43(5):419-430. PubMed ID: 32392908
[TBL] [Abstract][Full Text] [Related]
12. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
13. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.
Yang G; Badeanlou L; Bielawski J; Roberts AJ; Hannun YA; Samad F
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E211-24. PubMed ID: 19435851
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes.
Guitton J; Bandet CL; Mariko ML; Tan-Chen S; Bourron O; Benomar Y; Hajduch E; Le Stunff H
Cells; 2020 Jul; 9(7):. PubMed ID: 32668665
[TBL] [Abstract][Full Text] [Related]
15. Ceramides and Sphingosino-1-Phosphate in Obesity.
Juchnicka I; Kuźmicki M; Szamatowicz J
Front Endocrinol (Lausanne); 2021; 12():635995. PubMed ID: 34054722
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic endoplasmic reticulum stress as a key mediator of obesity-induced leptin resistance.
Ye Z; Liu G; Guo J; Su Z
Obes Rev; 2018 Jun; 19(6):770-785. PubMed ID: 29514392
[TBL] [Abstract][Full Text] [Related]
17. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
[TBL] [Abstract][Full Text] [Related]
18. Hypothalamic Lipids: Key Regulators of Whole Body Energy Balance.
González-García I; Fernø J; Diéguez C; Nogueiras R; López M
Neuroendocrinology; 2017; 104(4):398-411. PubMed ID: 27728904
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
[TBL] [Abstract][Full Text] [Related]
20. Feeding Stimulates Sphingosine-1-Phosphate Mobilization in Mouse Hypothalamus.
Vozella V; Realini N; Misto A; Piomelli D
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
